Treatment outcome of women with a single ovary undergoing in vitro fertilisation cycles

Singapore Med J. 2010 Sep;51(9):698-701.

Abstract

Introduction: Women with a single ovary present a unique problem in assisted reproductive techniques. The aim of our study was to compare the ovarian response and pregnancy rates of women with one ovary and those with two ovaries in assisted reproduction.

Methods: A total of 18 consecutive women with a single ovary (n is 22 cycles) were identified. The control group included 44 women with two ovaries and mechanical infertility, who were selected as frequency-matched samples (2:1) to meet the distribution of age at treatment and race in the single ovary group. All patients underwent controlled ovarian hyperstimulation treatment via the long down-regulation protocol using a gonadotropin-releasing hormone agonist. Standard procedures were carried out for gamete-embryo handling, and embryo transfer was performed using a soft catheter on day two in all cases. The luteal phase was supported by progesterone or Pregnyl after oocyte pick-up.

Results: The duration of stimulation (11.3 +/- 1.7 versus 10.1 +/- 1.4 days) and the total follicle stimulating hormone (FSH) consumption (3906.8 +/- 1860.6 mIU/ml versus 2900.0 +/- 1440.0 mIU/ml) were significantly higher, and the mean number of oocytes (10.8 +/- 4.5 versus 16.8 +/- 10.9) and metaphase II oocytes collected (9.5 +/- 4.5 versus 13.3 +/- 7.7) were significantly lower in the single ovary group (p is less than 0.05). The clinical pregnancy rates (31.8 percent versus 43.2 percent) were comparable between the two groups.

Conclusion: Although women with a single ovary required significantly higher doses of FSH and a longer duration of stimulation, as well as produced less oocytes, their clinical pregnancy rates were comparable to those of women with two ovaries in assisted reproduction.

MeSH terms

  • Adult
  • Chorionic Gonadotropin / pharmacology
  • Embryo Transfer
  • Female
  • Fertilization in Vitro / methods*
  • Follicle Stimulating Hormone / therapeutic use
  • Gonadotropin-Releasing Hormone / agonists
  • Humans
  • Infertility / diagnosis
  • Infertility / therapy
  • Oocytes / cytology
  • Ovary / pathology*
  • Pregnancy
  • Pregnancy Rate
  • Progesterone / metabolism
  • Treatment Outcome

Substances

  • Chorionic Gonadotropin
  • Gonadotropin-Releasing Hormone
  • Progesterone
  • Follicle Stimulating Hormone